Notable Tuesday Option Activity: LLY, CRWD, GS

Intraday options activity was unusually heavy in CrowdStrike and Goldman Sachs: CRWD traded 21,914 option contracts (~2.2M underlying shares), about 103.2% of its one-month average daily volume (2.1M shares), led by 1,606 contracts in the $80 call expiring Jan. 16, 2026 (~160,600 shares). GS traded 21,742 option contracts (~2.2M underlying shares), about 100.2% of its one-month average (2.2M shares), led by 535 contracts in the $950 call expiring Jan. 16, 2026 (~53,500 shares). The concentrated call flows suggest notable bullish positioning or hedging interest ahead of the Jan 2026 expiries and could influence near-term liquidity and price dynamics.

Analysis

Market structure: The concentric call flow in CRWD (≈21,914 contracts ≈2.2M shares, ~103% ADV) and GS (≈21,742 contracts ≈2.2M shares, ~100% ADV) signals outsized directional positioning that benefits options dealers (NDAQ/market-makers) via elevated IV and delta-hedging flows and can mechanically push equities higher as dealers buy stock to hedge. Direct winners are CRWD and GS long holders and liquidity providers capturing widened spreads; losers are short-vol sellers and passive funds facing transient tracking noise. Cross-asset: expect a small lift in single-name equity vols, transient tightening of credit spreads if GS outperforms, and negligible FX/commodity impact absent macro surprise.

Risk assessment: Tail risks include a CRWD data/privacy regulatory event or a GS credit/regulatory shock that could unwind long calls (low probability, high impact). Immediate (days) — IV spikes and dealer gamma hedging; short-term (weeks/months) — earnings/Fed risks that can reprice positions; long-term (to Jan 16, 2026) — binary outcomes (M&A, secular growth). Hidden dependency: large long-dated call buys may be part of structured hedges or institutional replacement trades (not pure directional), so flows can reverse rapidly if counterparties deleverage.

Trade implications: For directional exposure prefer defined-risk structures: establish a 1–2% portfolio long in CRWD equity or buy Jan 16, 2026 80/120 call spread sized to 0.5–1% notional (target +40% by expiry, stop -15% equity). For GS, consider a smaller Jan 16, 2026 950/1150 call spread (0.5% notional) or buy 3–6 month outright equity exposure ahead of results. If implied vol >30–35% for CRWD, sell short-dated (30–60d) OTM calls against stock or sell 30–60d put credit spreads to collect premium, size conservatively (max 1% portfolio).

Contrarian angles: The headline call volume can be misleading — flows may be cheap long-dated tail hedges or delta-adjusting baskets; don't assume pure bullish retail mania. If IV has repriced >25–30% vs three-month average, selling calibrated premium (calendar or diagonal spreads) is attractive. Historical parallels (2020/2021 concentrated call clusters) show rapid mean reversion once catalysts resolve, so prefer spreads to outright longs to avoid IV decay and large gamma squeezes.

Key Decisions for Investors

• Establish a 1–2% portfolio long position in CRWD equity within 5 trading days, set a tactical stop-loss at 15% below entry, and target a 40% upside through Jan 16, 2026; hedge position by buying the Jan 16, 2026 80/120 call spread if implied vol >30% to cap premium spend.
• Allocate 0.5–1.0% notional to GS via a Jan 16, 2026 950/1150 call spread (defined-risk bullish) sized so max loss = 0.5% portfolio; trim if GS outperforms by >20% or if macro risk-free rate moves >50bp intra-quarter.
• If CRWD implied volatility for 30–60d tenor exceeds its 3-month average by >25% (threshold to measure in next 10 trading days), sell 30–60d OTM call or put credit spreads (max sizing 1% portfolio) to harvest elevated premium, avoiding naked short exposure.
• Reduce non-core cybersecurity exposure by 1–2% and rotate proceeds into core names (CRWD via defined-risk spreads and GS call spreads) over next 2–6 weeks; reassess after quarterly earnings (next 30–60 days) and unwind if catalysts fail to materialize.